> top > docs > PMC:1064895 > spans > 2420-2921 > annotations

PMC:1064895 / 2420-2921 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T2189 342-360 Protein denotes interleukin (IL)-1
T2188 307-336 Protein denotes tumor necrosis factor (TNF)-α
T2187 293-303 Negative_regulation denotes inhibitors
T2155 342-360 Protein denotes interleukin (IL)-1
T2154 307-336 Protein denotes tumor necrosis factor (TNF)-α
R1090 T2188 T2187 themeOf tumor necrosis factor (TNF)-α,inhibitors
R1091 T2189 T2187 themeOf interleukin (IL)-1,inhibitors

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T3714 342-360 Protein denotes interleukin (IL)-1
T3713 307-336 Protein denotes tumor necrosis factor (TNF)-α
T3746 293-303 Negative_regulation denotes inhibitors
R1776 T3713 T3746 themeOf tumor necrosis factor (TNF)-α,inhibitors
R1777 T3714 T3746 themeOf interleukin (IL)-1,inhibitors

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T4635 293-303 Negative_regulation denotes inhibitors
T4603 342-360 Protein denotes interleukin (IL)-1
T4602 307-336 Protein denotes tumor necrosis factor (TNF)-α
R2458 T4602 T4635 themeOf tumor necrosis factor (TNF)-α,inhibitors
R2459 T4603 T4635 themeOf interleukin (IL)-1,inhibitors

2_test

Id Subject Object Predicate Lexical cue
15642134-12810425-4202008 243-244 12810425 denotes 1
15642134-12810200-4202009 498-499 12810200 denotes 2

biosemtest

Id Subject Object Predicate Lexical cue
T2741 473-484 UMLS/C0302350 denotes herapeutic
T2738 307-328 UP/P13296 denotes tumor necrosis factor
T2734 229-235 UMLS/C0444497 denotes joints
T2733 96-101 UMLS/C0444497 denotes joint
T2717 261-269 UMLS/C0205210 denotes clinical
T2711 307-328 UP/P59694 denotes tumor necrosis factor
T2704 307-328 UP/P19101 denotes tumor necrosis factor
T2697 469-472 UMLS/C0205314 denotes ew
T2693 185-190 UMLS/C0205309 denotes known
T2692 307-328 UP/O77764 denotes tumor necrosis factor
T2691 261-269 UMLS/C1555900 denotes clinical
T2688 307-328 UP/P51435 denotes tumor necrosis factor
T2678 307-328 UP/Q8MKG8 denotes tumor necrosis factor
T2676 63-74 UMLS/C0024432 denotes macrophages
T2672 175-180 UMLS/C0007634 denotes cells
T2671 307-328 UP/P59684 denotes tumor necrosis factor
T2665 485-497 UMLS/C0870325 denotes pplications
T2664 261-269 UMLS/C1611832 denotes clinical
T2657 307-328 UP/P36939 denotes tumor necrosis factor
T2656 307-328 UP/Q8JFG3 denotes tumor necrosis factor
T2653 116-127 UMLS/C0020507 denotes hyperplasia
T2647 307-328 UP/P33620 denotes tumor necrosis factor
T2642 307-328 UP/P79374 denotes tumor necrosis factor
T2641 107-115 UMLS/C1550315 denotes synovial
T2640 155-163 UMLS/C0439180 denotes released
T2637 307-328 UP/Q06599 denotes tumor necrosis factor
T2636 307-328 UP/P59695 denotes tumor necrosis factor
T2635 307-328 UP/P79337 denotes tumor necrosis factor
T2633 307-328 UP/P59693 denotes tumor necrosis factor
T2632 307-328 UP/O35734 denotes tumor necrosis factor
T2627 155-163 UMLS/C0680255 denotes released
T2624 261-269 UMLS/C1608518 denotes clinical
T2623 307-328 UP/P29553 denotes tumor necrosis factor
T2622 307-328 UP/P23563 denotes tumor necrosis factor
T2621 307-328 UP/Q8HZD9 denotes tumor necrosis factor
T2603 391-394 UMLS/C1554080 denotes ey
T2593 229-235 UMLS/C1706309 denotes joints
T2592 96-101 UMLS/C1706309 denotes joint
T2587 63-74 UMLS/C1550652 denotes macrophages
T2584 307-328 UP/P23383 denotes tumor necrosis factor
T2575 307-328 UP/Q1G1A2 denotes tumor necrosis factor
T2573 46-59 UMLS/C0332448 denotes infiltrations
T2568 307-328 UP/Q8WNR1 denotes tumor necrosis factor
T2561 307-328 UMLS/C1456820 denotes tumor necrosis factor
T2559 307-328 UP/Q9BEA1 denotes tumor necrosis factor
T2558 485-497 UMLS/C2347934 denotes pplications
T2556 307-328 UP/Q19LH4 denotes tumor necrosis factor
T2555 29-42 UMLS/C1880022 denotes characterized
T2541 469-472 UMLS/C1553390 denotes ew
T2479 175-180 UMLS/C1136359 denotes cells
T2475 279-287 UMLS/C1706701 denotes obtained
T2474 307-328 UMLS/C2700093 denotes tumor necrosis factor
T2472 270-278 UMLS/C0814225 denotes benefits
T2470 485-497 UMLS/C0185125 denotes pplications
T2466 175-180 UMLS/C1948049 denotes cells
T2465 307-328 UP/Q2MH05 denotes tumor necrosis factor
T2464 293-303 UMLS/C1999216 denotes inhibitors
T2463 307-328 UMLS/C0041368 denotes tumor necrosis factor
T2458 307-328 UP/Q539C2 denotes tumor necrosis factor
T2453 0-20 UMLS/C0003873 denotes Rheumatoid arthritis
T2447 473-484 UMLS/C1553525 denotes herapeutic
T2442 214-225 UMLS/C1948029 denotes destruction
T2438 279-287 UMLS/C1301820 denotes obtained
T2437 155-163 UMLS/C1963578 denotes released
T2435 454-465 UMLS/C1527148 denotes evelopment
T2433 63-74 UMLS/C1546706 denotes macrophages
T2428 307-328 UP/P04924 denotes tumor necrosis factor
T2427 307-328 UP/P01375 denotes tumor necrosis factor
T2420 307-328 UP/P16599 denotes tumor necrosis factor
T2412 408-417 UMLS/C1524094 denotes ytokines
T2411 145-154 UMLS/C1524094 denotes cytokines
T2403 469-472 UMLS/C1578513 denotes ew
T2395 343-354 UMLS/C0021764 denotes nterleukin
T2381 391-394 UMLS/C1706198 denotes ey
T2372 307-328 UP/P51743 denotes tumor necrosis factor
T2358 175-180 UMLS/C1704653 denotes cells
T2345 379-387 UMLS/C0332206 denotes lockade
T2335 307-328 UMLS/C1323304 denotes tumor necrosis factor
T2334 214-225 UMLS/C1261381 denotes destruction
T2333 343-354 UMLS/C1527200 denotes nterleukin
T2332 307-328 UP/O77510 denotes tumor necrosis factor
T2330 229-235 UMLS/C0392905 denotes joints
T2329 96-101 UMLS/C0392905 denotes joint
T2328 307-328 UP/Q75N23 denotes tumor necrosis factor
T2326 229-235 UMLS/C1269611 denotes joints
T2325 96-101 UMLS/C1269611 denotes joint
T2324 293-303 UMLS/C0243077 denotes inhibitors
T2297 175-180 UMLS/C1269647 denotes cells
T2295 485-497 UMLS/C1947919 denotes pplications
T2286 155-163 UMLS/C1283071 denotes released
T2283 473-484 UMLS/C0039796 denotes herapeutic
T2282 307-328 UMLS/C1522668 denotes tumor necrosis factor
T2281 362-369 UMLS/C1705535 denotes uggest
T2533 418-421 UMLS/C2348947 denotes as
T2528 79-86 UMLS/C0039194 denotes T cells
T2509 229-235 UMLS/C0022417 denotes joints
T2508 96-101 UMLS/C0022417 denotes joint
T2505 307-328 UP/P06804 denotes tumor necrosis factor
T2499 485-497 UMLS/C1547755 denotes pplications
T2493 307-328 UP/Q1WM27 denotes tumor necrosis factor
T2272 191-193 UMLS/C0319022 denotes to
T2266 46-59 UMLS/C0702249 denotes infiltrations
T2265 485-497 UMLS/C1533134 denotes pplications
T2260 395-407 UMLS/C0333348 denotes nflammatory
T2258 307-328 UP/P51742 denotes tumor necrosis factor
T2252 473-484 UMLS/C1547427 denotes herapeutic
T2250 46-59 UMLS/C1523986 denotes infiltrations
T2249 155-163 UMLS/C0391871 denotes released
T2242 408-417 UMLS/C0079189 denotes ytokines
T2241 145-154 UMLS/C0079189 denotes cytokines
T2236 307-328 UP/P48094 denotes tumor necrosis factor

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T2979 499-500 -RRB- denotes ]
T2978 498-499 CD denotes 2
T2977 497-498 -LRB- denotes [
T2976 484-496 NN denotes applications
T2975 472-483 JJ denotes therapeutic
T2974 468-471 JJ denotes new
T2973 465-467 IN denotes of
T2972 453-464 NN denotes development
T2971 449-452 DT denotes the
T2970 446-448 IN denotes in
T2969 440-445 NN denotes issue
T2968 430-439 JJ denotes important
T2967 426-429 DT denotes the
T2966 421-425 VB denotes been
T2965 417-420 VB denotes has
T2964 407-416 NN denotes cytokines
T2963 394-406 JJ denotes inflammatory
T2962 390-393 JJ denotes key
T2961 387-389 IN denotes of
T2960 378-386 NN denotes blockade
T2959 374-377 DT denotes the
T2958 369-373 IN denotes that
T2957 361-368 VB denotes suggest
T2956 358-360 CD denotes -1
T2955 357-358 -RRB- denotes )
T2954 355-357 NN denotes IL
T2953 354-355 -LRB- denotes (
T2952 342-353 NN denotes interleukin
T2951 338-341 CC denotes and
T2950 336-337 -RRB- denotes )
T2949 334-336 NN denotes -α
T2948 333-334 -RRB- denotes )
T2947 330-333 NN denotes TNF
T2946 329-330 -LRB- denotes (
T2945 322-328 NN denotes factor
T2944 313-321 NN denotes necrosis
T2943 307-312 NN denotes tumor
T2942 304-306 IN denotes of
T2941 293-303 NN denotes inhibitors
T2940 288-292 IN denotes with
T2939 279-287 VB denotes obtained
T2938 270-278 NN denotes benefits
T2937 261-269 JJ denotes clinical
T2936 251-260 JJ denotes favorable
T2935 247-250 DT denotes The
T2934 244-245 -RRB- denotes ]
T2933 243-244 CD denotes 1
T2932 242-243 -LRB- denotes [
T2931 239-241 NN denotes RA
T2930 236-238 IN denotes in
T2929 229-235 NN denotes joints
T2928 226-228 IN denotes of
T2927 214-225 NN denotes destruction
T2926 210-213 DT denotes the
T2925 207-209 IN denotes in
T2924 197-206 JJ denotes important
T2923 194-196 VB denotes be
T2922 191-193 TO denotes to
T2921 185-190 VB denotes known
T2920 181-184 VB denotes are
T2919 175-180 NN denotes cells
T2918 169-174 DT denotes these
T2917 164-168 IN denotes from
T2916 155-163 VB denotes released
T2915 145-154 NN denotes cytokines
T2914 129-144 JJ denotes Proinflammatory
T2913 116-127 NN denotes hyperplasia
T2912 107-115 JJ denotes synovial
T2911 103-106 CC denotes and
T2910 101-102 -COMMA- denotes ,
T2909 96-101 NN denotes joint
T2908 92-95 DT denotes the
T2907 87-91 IN denotes into
T2906 81-86 NN denotes cells
T2905 79-80 NN denotes T
T2904 75-78 CC denotes and
T2903 63-74 NN denotes macrophages
T2902 60-62 IN denotes of
T2901 46-59 NN denotes infiltrations
T2900 43-45 IN denotes by
T2899 29-42 VB denotes characterized
T2898 26-28 VB denotes is
T2897 24-25 -RRB- denotes )
T2896 22-24 NN denotes RA
T2895 21-22 -LRB- denotes (
T2894 11-20 NN denotes arthritis
T2893 0-10 JJ denotes Rheumatoid
R1151 T2894 T2893 arg1Of arthritis,Rheumatoid
R1152 T2894 T2895 arg1Of arthritis,(
R1153 T2894 T2898 arg1Of arthritis,is
R1154 T2894 T2899 arg2Of arthritis,characterized
R1155 T2896 T2895 arg2Of RA,(
R1156 T2897 T2895 arg3Of ),(
R1157 T2899 T2898 arg2Of characterized,is
R1158 T2901 T2899 arg1Of infiltrations,characterized
R1159 T2901 T2900 arg2Of infiltrations,by
R1160 T2901 T2902 arg1Of infiltrations,of
R1161 T2903 T2904 arg1Of macrophages,and
R1162 T2904 T2907 arg1Of and,into
R1163 T2904 T2911 arg1Of and,and
R1164 T2906 T2904 arg2Of cells,and
R1165 T2906 T2905 arg1Of cells,T
R1166 T2909 T2907 arg2Of joint,into
R1167 T2909 T2908 arg1Of joint,the
R1168 T2911 T2902 arg2Of and,of
R1169 T2911 T2910 arg1Of and,","
R1170 T2913 T2911 arg2Of hyperplasia,and
R1171 T2913 T2912 arg1Of hyperplasia,synovial
R1172 T2915 T2914 arg1Of cytokines,Proinflammatory
R1173 T2915 T2916 arg2Of cytokines,released
R1174 T2915 T2920 arg1Of cytokines,are
R1175 T2915 T2921 arg2Of cytokines,known
R1176 T2915 T2923 arg1Of cytokines,be
R1177 T2915 T2924 arg1Of cytokines,important
R1178 T2916 T2917 arg1Of released,from
R1179 T2919 T2917 arg2Of cells,from
R1180 T2919 T2918 arg1Of cells,these
R1181 T2921 T2920 arg2Of known,are
R1182 T2921 T2932 arg1Of known,[
R1183 T2923 T2921 arg3Of be,known
R1184 T2923 T2922 arg1Of be,to
R1185 T2924 T2923 arg2Of important,be
R1186 T2924 T2925 arg1Of important,in
R1187 T2927 T2925 arg2Of destruction,in
R1188 T2927 T2926 arg1Of destruction,the
R1189 T2927 T2928 arg1Of destruction,of
R1190 T2927 T2930 arg1Of destruction,in
R1191 T2929 T2928 arg2Of joints,of
R1192 T2931 T2930 arg2Of RA,in
R1193 T2933 T2932 arg2Of 1,[
R1194 T2934 T2932 arg3Of ],[
R1195 T2938 T2935 arg1Of benefits,The
R1196 T2938 T2936 arg1Of benefits,favorable
R1197 T2938 T2937 arg1Of benefits,clinical
R1198 T2938 T2939 arg2Of benefits,obtained
R1199 T2938 T2950 arg1Of benefits,)
R1200 T2938 T2951 arg1Of benefits,and
R1201 T2939 T2940 arg1Of obtained,with
R1202 T2941 T2940 arg2Of inhibitors,with
R1203 T2941 T2942 arg1Of inhibitors,of
R1204 T2945 T2943 arg1Of factor,tumor
R1205 T2945 T2944 arg1Of factor,necrosis
R1206 T2945 T2946 arg1Of factor,(
R1207 T2947 T2946 arg2Of TNF,(
R1208 T2948 T2946 arg3Of ),(
R1209 T2949 T2942 arg2Of -α,of
R1210 T2949 T2945 arg1Of -α,factor
R1211 T2951 T2957 arg1Of and,suggest
R1212 T2952 T2951 arg2Of interleukin,and
R1213 T2952 T2953 arg1Of interleukin,(
R1214 T2952 T2956 arg1Of interleukin,-1
R1215 T2954 T2953 arg2Of IL,(
R1216 T2955 T2953 arg3Of ),(
R1217 T2960 T2959 arg1Of blockade,the
R1218 T2960 T2961 arg1Of blockade,of
R1219 T2960 T2965 arg1Of blockade,has
R1220 T2960 T2966 arg1Of blockade,been
R1221 T2964 T2961 arg2Of cytokines,of
R1222 T2964 T2962 arg1Of cytokines,key
R1223 T2964 T2963 arg1Of cytokines,inflammatory
R1224 T2966 T2957 arg2Of been,suggest
R1225 T2966 T2958 arg1Of been,that
R1226 T2966 T2965 arg2Of been,has
R1227 T2966 T2970 arg1Of been,in
R1228 T2966 T2977 arg1Of been,[
R1229 T2969 T2966 arg2Of issue,been
R1230 T2969 T2967 arg1Of issue,the
R1231 T2969 T2968 arg1Of issue,important
R1232 T2972 T2970 arg2Of development,in
R1233 T2972 T2971 arg1Of development,the
R1234 T2972 T2973 arg1Of development,of
R1235 T2976 T2973 arg2Of applications,of
R1236 T2976 T2974 arg1Of applications,new
R1237 T2976 T2975 arg1Of applications,therapeutic
R1238 T2978 T2977 arg2Of 2,[
R1239 T2979 T2977 arg3Of ],[

bionlp-st-ge-2016-coref

Id Subject Object Predicate Lexical cue
T3464 342-360 Antecedent denotes interleukin (IL)-1
T3463 307-336 Antecedent denotes tumor necrosis factor (TNF)-α
T3462 390-416 Anaphor denotes key inflammatory cytokines
R1726 T3462 T3463 boundBy key inflammatory cytokines,tumor necrosis factor (TNF)-α
R1728 T3462 T3464 boundBy key inflammatory cytokines,interleukin (IL)-1

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T3483 342-360 Protein denotes interleukin (IL)-1
T3482 307-336 Protein denotes tumor necrosis factor (TNF)-α

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T3688 330-336 http://www.uniprot.org/uniprot/P01375 denotes TNF)-α
T3686 330-333 http://www.uniprot.org/uniprot/P01375 denotes TNF

GO-BP

Id Subject Object Predicate Lexical cue
T2770 453-464 http://purl.obolibrary.org/obo/GO_0032502 denotes development
T2769 313-321 http://purl.obolibrary.org/obo/GO_0070265 denotes necrosis
T2768 313-321 http://purl.obolibrary.org/obo/GO_0019835 denotes necrosis
T2767 313-321 http://purl.obolibrary.org/obo/GO_0008219 denotes necrosis
T2766 313-321 http://purl.obolibrary.org/obo/GO_0001906 denotes necrosis

GO-MF

Id Subject Object Predicate Lexical cue
T3515 355-360 http://purl.obolibrary.org/obo/GO_0005149 denotes IL)-1

GO-CC

Id Subject Object Predicate Lexical cue
T3553 175-180 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T3552 81-86 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

sentences

Id Subject Object Predicate Lexical cue
T2750 247-501 Sentence denotes The favorable clinical benefits obtained with inhibitors of tumor necrosis factor (TNF)-α) and interleukin (IL)-1 suggest that the blockade of key inflammatory cytokines has been the important issue in the development of new therapeutic applications [2].
T2749 129-246 Sentence denotes Proinflammatory cytokines released from these cells are known to be important in the destruction of joints in RA [1].
T2748 0-128 Sentence denotes Rheumatoid arthritis (RA) is characterized by infiltrations of macrophages and T cells into the joint, and synovial hyperplasia.
T18 0-128 Sentence denotes Rheumatoid arthritis (RA) is characterized by infiltrations of macrophages and T cells into the joint, and synovial hyperplasia.
T19 129-246 Sentence denotes Proinflammatory cytokines released from these cells are known to be important in the destruction of joints in RA [1].
T20 247-501 Sentence denotes The favorable clinical benefits obtained with inhibitors of tumor necrosis factor (TNF)-α) and interleukin (IL)-1 suggest that the blockade of key inflammatory cytokines has been the important issue in the development of new therapeutic applications [2].

ICD10

Id Subject Object Predicate Lexical cue
T3567 11-20 http://purl.bioontology.org/ontology/ICD10/M13.9 denotes arthritis
T3566 0-20 http://purl.bioontology.org/ontology/ICD10/M06.9 denotes Rheumatoid arthritis

simple1

Id Subject Object Predicate Lexical cue
T3654 342-360 Protein denotes interleukin (IL)-1
T3653 307-336 Protein denotes tumor necrosis factor (TNF)-α

DLUT931

Id Subject Object Predicate Lexical cue
T3795 293-303 Negative_regulation denotes inhibitors
T3763 342-360 Protein denotes interleukin (IL)-1
T3762 307-336 Protein denotes tumor necrosis factor (TNF)-α
R1780 T3762 T3795 themeOf tumor necrosis factor (TNF)-α,inhibitors
R1782 T3763 T3795 themeOf interleukin (IL)-1,inhibitors

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T4592 145-180 Regulation denotes cytokines released from these cells
T4582 79-86 Entity denotes T cells
T4581 293-336 Entity denotes inhibitors of tumor necrosis factor (TNF)-α
T4567 307-336 Protein denotes tumor necrosis factor (TNF)-α
T4558 394-416 Protein denotes inflammatory cytokines
T4551 63-74 Entity denotes macrophages
T4537 169-180 Entity denotes these cells
T4527 145-180 Protein denotes cytokines released from these cells
T4525 342-360 Protein denotes interleukin (IL)-1
T4521 239-241 Protein denotes RA
T4518 22-24 Protein denotes RA
R2455 T4527 T4592 themeOf cytokines released from these cells,cytokines released from these cells

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T3942 500-501 . denotes .
T3941 499-500 NN denotes ]
T3940 498-499 CD denotes 2
T3939 497-498 JJ denotes [
T3938 484-496 NNS denotes applications
T3937 472-483 JJ denotes therapeutic
T3936 468-471 JJ denotes new
T3935 465-467 IN denotes of
T3934 453-464 NN denotes development
T3933 449-452 DT denotes the
T3932 446-448 IN denotes in
T3931 440-445 NN denotes issue
T3930 430-439 JJ denotes important
T3929 426-429 DT denotes the
T3928 421-425 VBN denotes been
T3927 417-420 VBZ denotes has
T3926 407-416 NNS denotes cytokines
T3925 394-406 JJ denotes inflammatory
T3924 390-393 JJ denotes key
T3923 387-389 IN denotes of
T3922 378-386 NN denotes blockade
T3921 374-377 DT denotes the
T3920 369-373 IN denotes that
T3919 361-368 VBP denotes suggest
T3918 358-360 CD denotes -1
T3917 357-358 -RRB- denotes )
T3916 355-357 NNP denotes IL
T3915 354-355 -LRB- denotes (
T3914 342-353 NN denotes interleukin
T3913 338-341 CC denotes and
T3912 336-337 -RRB- denotes )
T3911 335-336 VBN denotes α
T3910 334-335 : denotes -
T3909 333-334 -RRB- denotes )
T3908 330-333 NNP denotes TNF
T3907 329-330 -LRB- denotes (
T3906 322-328 NN denotes factor
T3905 313-321 NN denotes necrosis
T3904 307-312 NN denotes tumor
T3903 304-306 IN denotes of
T3902 293-303 NNS denotes inhibitors
T3901 288-292 IN denotes with
T3900 279-287 VBN denotes obtained
T3899 270-278 NNS denotes benefits
T3898 261-269 JJ denotes clinical
T3897 251-260 JJ denotes favorable
T3896 247-250 DT denotes The
T3895 245-246 . denotes .
T3894 244-245 NNP denotes ]
T3893 243-244 CD denotes 1
T3892 242-243 NNP denotes [
T3891 239-241 NNP denotes RA
T3890 236-238 IN denotes in
T3889 229-235 NNS denotes joints
T3888 226-228 IN denotes of
T3887 214-225 NN denotes destruction
T3886 210-213 DT denotes the
T3885 207-209 IN denotes in
T3884 197-206 JJ denotes important
T3883 194-196 VB denotes be
T3882 191-193 TO denotes to
T3881 185-190 VBN denotes known
T3880 181-184 VBP denotes are
T3879 175-180 NNS denotes cells
T3878 169-174 DT denotes these
T3877 164-168 IN denotes from
T3876 155-163 VBN denotes released
T3875 145-154 NNS denotes cytokines
T3874 129-144 JJ denotes Proinflammatory
T3873 127-128 . denotes .
T3872 116-127 NN denotes hyperplasia
T3871 107-115 JJ denotes synovial
T3870 103-106 CC denotes and
T3869 101-102 , denotes ,
T3868 96-101 JJ denotes joint
T3867 92-95 DT denotes the
T3866 87-91 IN denotes into
T3865 81-86 NNS denotes cells
T3864 79-80 NNP denotes T
T3863 75-78 CC denotes and
T3862 63-74 NNS denotes macrophages
T3861 60-62 IN denotes of
T3860 46-59 NNS denotes infiltrations
T3859 43-45 IN denotes by
T3858 29-42 VBN denotes characterized
T3857 26-28 VBZ denotes is
T3856 24-25 -RRB- denotes )
T3855 22-24 NNP denotes RA
T3854 21-22 -LRB- denotes (
T3853 11-20 NNS denotes arthritis
T3852 0-10 JJ denotes Rheumatoid
R1821 T3852 T3853 amod Rheumatoid,arthritis
R1822 T3853 T3858 nsubjpass arthritis,characterized
R1823 T3854 T3853 punct (,arthritis
R1824 T3855 T3853 appos RA,arthritis
R1828 T3856 T3853 punct ),arthritis
R1829 T3857 T3858 auxpass is,characterized
R1832 T3858 T3858 ROOT characterized,characterized
R1833 T3859 T3858 agent by,characterized
R1836 T3860 T3859 pobj infiltrations,by
R1838 T3861 T3860 prep of,infiltrations
R1841 T3862 T3861 pobj macrophages,of
R1843 T3863 T3862 cc and,macrophages
R1845 T3864 T3865 compound T,cells
R1846 T3865 T3862 conj cells,macrophages
R1847 T3866 T3858 prep into,characterized
R1848 T3867 T3868 det the,joint
R1849 T3868 T3872 amod joint,hyperplasia
R1850 T3869 T3868 punct ",",joint
R1852 T3870 T3868 cc and,joint
R1855 T3871 T3868 conj synovial,joint
R1858 T3872 T3866 pobj hyperplasia,into
R1861 T3873 T3858 punct .,characterized
R1865 T3874 T3875 amod Proinflammatory,cytokines
R1869 T3875 T3881 nsubjpass cytokines,known
R1873 T3876 T3875 acl released,cytokines
R1878 T3877 T3876 prep from,released
R1880 T3878 T3879 det these,cells
R1883 T3879 T3877 pobj cells,from
R1887 T3880 T3881 auxpass are,known
R1891 T3881 T3881 ROOT known,known
R1894 T3882 T3883 aux to,be
R1898 T3883 T3881 xcomp be,known
R1901 T3884 T3883 acomp important,be
R1905 T3885 T3883 prep in,be
R1909 T3886 T3887 det the,destruction
R1913 T3887 T3885 pobj destruction,in
R1918 T3888 T3887 prep of,destruction
R1922 T3889 T3888 pobj joints,of
R1923 T3890 T3887 prep in,destruction
R1925 T3891 T3892 compound RA,[
R1929 T3892 T3890 pobj [,in
R1934 T3893 T3894 nummod 1,]
R1939 T3894 T3892 appos ],[
R1942 T3895 T3881 punct .,known
R1947 T3896 T3899 det The,benefits
R1951 T3897 T3899 amod favorable,benefits
R1955 T3898 T3899 amod clinical,benefits
R1958 T3899 T3911 nsubj benefits,α
R1962 T3900 T3899 acl obtained,benefits
R1966 T3901 T3900 prep with,obtained
R1969 T3902 T3901 pobj inhibitors,with
R1973 T3903 T3902 prep of,inhibitors
R1977 T3904 T3905 compound tumor,necrosis
R1983 T3905 T3906 compound necrosis,factor
R1984 T3906 T3903 pobj factor,of
R1985 T3907 T3908 punct (,TNF
R1988 T3908 T3906 appos TNF,factor
R1990 T3909 T3900 punct ),obtained
R1993 T3910 T3899 punct -,benefits
R1997 T3911 T3911 ROOT α,α
R2000 T3912 T3911 punct ),α
R2004 T3913 T3911 cc and,α
R2008 T3914 T3919 nsubj interleukin,suggest
R2012 T3915 T3916 punct (,IL
R2015 T3916 T3914 appos IL,interleukin
R2019 T3917 T3918 punct ),-1
R2023 T3918 T3919 nsubj -1,suggest
R2026 T3919 T3911 conj suggest,α
R2033 T3920 T3928 mark that,been
R2037 T3921 T3922 det the,blockade
R2041 T3922 T3928 nsubj blockade,been
R2045 T3923 T3922 prep of,blockade
R2048 T3924 T3926 amod key,cytokines
R2052 T3925 T3926 amod inflammatory,cytokines
R2056 T3926 T3923 pobj cytokines,of
R2060 T3927 T3928 aux has,been
R2064 T3928 T3919 ccomp been,suggest
R2068 T3929 T3931 det the,issue
R2071 T3930 T3931 amod important,issue
R2075 T3931 T3928 attr issue,been
R2079 T3932 T3931 prep in,issue
R2081 T3933 T3934 det the,development
R2084 T3934 T3932 pobj development,in
R2087 T3935 T3934 prep of,development
R2091 T3936 T3938 amod new,applications
R2095 T3937 T3938 amod therapeutic,applications
R2097 T3938 T3935 pobj applications,of
R2100 T3939 T3941 amod [,]
R2104 T3940 T3941 nummod 2,]
R2107 T3941 T3931 conj ],issue
R2111 T3942 T3919 punct .,suggest

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T3604 293-303 Negative_regulation denotes inhibitors
T3603 293-303 Negative_regulation denotes inhibitors
T3602 342-360 Protein denotes interleukin (IL)-1
T3601 307-336 Protein denotes tumor necrosis factor (TNF)-α
R1751 T3601 T3603 themeOf tumor necrosis factor (TNF)-α,inhibitors
R1753 T3602 T3604 themeOf interleukin (IL)-1,inhibitors

testone

Id Subject Object Predicate Lexical cue
T2108 342-360 Protein denotes interleukin (IL)-1
T2107 307-336 Protein denotes tumor necrosis factor (TNF)-α